You are here

  • Home
  • Archive
  • Volume 78, Issue 8
  • Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials

Article metrics

Article menu
Download PDFPDF
Rheumatoid arthritis
Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials

 

Online download statistics by month:

Online download statistics by month: May 2019 to April 2023

AbstractFullPdf
May 20192503331235
Jun 20191624216124
Jul 20191930321190
Aug 20191016212125
Sep 201946611086
Oct 201957114093
Nov 20193958245
Dec 201943810163
Jan 20203495644
Feb 20203364632
Mar 20202816746
Apr 20203174841
May 20202484737
Jun 20202865561
Jul 20203273430
Aug 20202534550
Sep 20204117250
Oct 20204316552
Nov 20203615451
Dec 20203403634
Jan 20214743931
Feb 20215463748
Mar 20215085940
Apr 20214305136
May 20212884032
Jun 2021625137
Jul 2021554226
Aug 2021472717
Sep 20211008042
Oct 20214727439
Nov 20213866738
Dec 20213053825
Jan 20223916333
Feb 20224144730
Mar 20224664519
Apr 20223884033
May 20224175528
Jun 20224134629
Jul 20224533920
Aug 20222753519
Sep 20223696119
Oct 20224725714
Nov 20223884723
Dec 2022288219
Jan 2023259239
Feb 20233985028
Mar 20234015021
Apr 20232493021
Total2259734522255